OrthoPediatrics Corp. Stock 12‑Month Price Target Raised to $29, Implies 22% Upside
OrthoPediatrics Corp.'s average stock price target increased from $27.5 to $29, with estimates ranging from $23 to $35. This implies a 22% upside based on the Oct. 27 closing price. All 8 analysts rate the stock as Buy or Hold, with 7 Buys and 1 Hold.
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 7:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Decision brief
The 30-second read
Low
01
Why it matters
Analyst consensus upgrade may lead to modest price appreciation.
02
Market read
Target raise signals improved outlook but lacks a concrete catalyst.
03
What to watch
No new product or earnings data accompanies the target change.
Relevance 5/10Novelty 5/10Timing: current day
Background
OrthoPediatrics is a pediatric medical device company listed on Nasdaq.
Market effects
Sector
May lift sentiment in the pediatric medical device sector.
Regional
Limited to US biotech investors.
Global
Minimal global impact.
Counterpoint
What could challenge this read
Target raise could be premature if underlying fundamentals remain unchanged.
Key entities
- companyOrthoPediatrics Corp.
Pediatric medical device manufacturer.
